Any process that stops, prevents or reduces the frequency, rate or extent of deacetylase activity.

Combining with luteinizing hormone (also called lutropin) to initiate a change in cell activity.

Any process that activates or increases the frequency, rate or extent of histone deacetylase activity.

Any process that activates or increases the frequency, rate or extent of the removal of acetyl groups from histones.

Any process that activates or increases the frequency, rate or extent of deacetylase activity, the catalysis of the hydrolysis of an acetyl group or groups from a substrate molecule.

Combining with the amino acid gamma-aminobutyric acid (GABA, 4-aminobutyrate) and transmitting the signal across the membrane by activating an associated G-protein; promotes the exchange of GDP for GTP on the alpha subunit of a heterotrimeric G-protein complex.

Combining with gamma-aminobutyric acid (GABA), and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity. (GABA, 4-aminobutyrate) is an amino acid which acts as a neurotransmitter in some organisms.

The chemical reactions and pathways involving monensin A.

Combining with galanin to initiate a change in cell activity.

The chemical reactions and pathways resulting in the breakdown of monensin A.

Combining with glucagon and transmitting the signal across the membrane by activating an associated G-protein; promotes the exchange of GDP for GTP on the alpha subunit of a heterotrimeric G-protein complex.

Combining with gonadotropin-releasing hormone to initiate a change in cell activity. Gonadotropin-releasing hormone (GnRH) is a peptide hormone responsible for the release of follicle-stimulating hormone (FSH) and luteinizing hormone (LH) from the anterior pituitary. GnRH is synthesized and released by the hypothalamus.

Combining with histamine to initiate a change in cell activity. Histamine is a physiologically active amine, found in plant and animal tissue and released from mast cells as part of an allergic reaction in humans.

Any process that stops, prevents or reduces the frequency, rate or extent of miRNA metabolic process.

Any process that modulates the frequency, rate or extent of miRNA metabolic process.

Any process that stops, prevents or reduces the frequency, rate or extent of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay.

Any process that modulates the frequency, rate or extent of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay.

Any process that activates or increases the frequency, rate or extent of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay.

Any process that activates or increases the frequency, rate or extent of miRNA catabolic process.

Any process that activates or increases the frequency, rate or extent of miRNA metabolic process.